China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Capital Reinvestment Ratio
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Capital Reinvestment Ratio of 3.33x as of December 2025, meaning it reinvests 3% of its operating cash flow (CN¥36.82 Million) in capital expenditures (CN¥122.46 Million). Check tangible equity quality of China Resources Boya Bio pharmaceutical to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Resources Boya Bio pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks China Resources Boya Bio pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see China Resources Boya Bio pharmaceutical (300294) cash conversion ratio.
Annual Capital Reinvestment Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2025. See China Resources Boya Bio pharmaceutical (300294) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.59x | CN¥116.69 Million | CN¥535.31 Million | ▲ +595.3% |
| 2024 | 0.66x | CN¥299.78 Million | CN¥197.79 Million | ▲ +383.9% |
| 2023 | 0.14x | CN¥641.73 Million | CN¥87.50 Million | ▼ -41.2% |
| 2022 | 0.23x | CN¥596.44 Million | CN¥138.41 Million | ▲ +358.3% |
| 2021 | 0.05x | CN¥1.35 Billion | CN¥68.12 Million | ▼ -74.5% |
| 2020 | 0.20x | CN¥718.58 Million | CN¥142.51 Million | ▼ -93.9% |
| 2018 | 3.26x | CN¥34.90 Million | CN¥113.90 Million | ▲ +116.1% |
| 2016 | 1.51x | CN¥198.76 Million | CN¥300.09 Million | ▲ +39.3% |
| 2015 | 1.08x | CN¥147.02 Million | CN¥159.37 Million | ▲ +175.9% |
| 2014 | 0.39x | CN¥121.88 Million | CN¥47.89 Million | ▲ +6.4% |
| 2013 | 0.37x | CN¥89.11 Million | CN¥32.90 Million | ▲ +39.5% |
| 2012 | 0.26x | CN¥92.36 Million | CN¥24.45 Million | ▲ +18.1% |
| 2011 | 0.22x | CN¥81.53 Million | CN¥18.27 Million | ▼ -84.9% |
| 2010 | 1.48x | CN¥24.77 Million | CN¥36.65 Million | ▲ +38.6% |
| 2009 | 1.07x | CN¥51.88 Million | CN¥55.40 Million | — |